Primary Care Enhanced Services

Description

NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing Lot 1: NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is £27,320. The provider is an existing provider and the services are existing services.